Why Moderna's COVID Vaccine Is Just the Tip of the Iceberg

Keith Speights, The Motley Fool
·5 min read

Investors have been excited for quite a while now about Moderna's (NASDAQ: MRNA) COVID-19 vaccine, mRNA-1273. Moderna stands to make billions of dollars this year from the vaccine. In this Motley Fool Live video recorded on Jan. 13, 2021, healthcare and cannabis bureau chief Corinne Cardina and Fool.com writer Keith Speights discuss why Moderna's COVID-19 vaccine is just the tip of the iceberg for the company.